We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
CIMZIA (UCB Australia Pty Ltd)
Product name
CIMZIA
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
240 working days (255)
Active ingredients
certolizumab pegol
Registration type
EOI
Indication
Plaque psoriasis
CIMZIA (solution for injection) is now also indicated for the treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy.